Member of the Oxford Martin Management Committee

After a distinguished academic career at St Andrews, he arrived at the University of Oxford in 2017 as Professor of Structural Biology in the Nuffield Department of Medicine and Senior Research Fellow at Jesus College. He was seconded from Oxford to lead the Research Complex at Harwell from 2017 to 2019 and the Rosalind Franklin Institute (as interim co-Director and substantive Director) since its inception in 2018. He was part of the joint Oxford, Diamond and Franklin team that discovered nanobody treatment for COVID-19.

Jim is also Vice-President (non-clinical) of The Academy of Medical Sciences and Vice-Chair of the Council of the European X-Ray Free-Electron Laser. His research focuses on the structural and chemical biology of enzymes and recognition complexes.